CASP9 and lung cancer: The overexpression of Mcl-1L in PRKCSH-deficient cells suppressed TRAIL-mediated cell death and caspase-9 activation (Fig. 5g), whereas Mcl-1 depletion in lung cancer cells enhanced TRAIL-mediated cell death and caspase-9 activation (Fig. 5h).